Award recordCONTRACT

INTERCEPT PHARMACEUTICALS INC

PIID 36E79722A0011· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $0 net obligations· UEI GHNKCLBJRMK7· NY

Description

BPA CANCELLATION

Base award description: BLANKET PURCHASE AGREEMENT FOR OCALIVA

First action · last action
2022-01-25 · 2024-10-07
Transactions
6
First transaction's obligation
$0
Base + all options value (sum of deltas)
$15,000,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70027
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 6 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2022-01-25 · this action $0 · running total $0Modification P00001 · 2022-12-05 · this action $0 · running total $0Modification P00002 · 2022-12-27 · this action $0 · running total $0Modification P00003 · 2023-12-14 · this action $0 · running total $0Modification P00004 · 2023-12-29 · this action $0 · running total $0Modification P00005 · 2024-10-07 · this action $0 · running total $0
  • Base2022-01-25+$0= $0
  • Mod P000012022-12-05+$0= $0
  • Mod P000022022-12-27+$0= $0
  • Mod P000032023-12-14+$0= $0
  • Mod P000042023-12-29+$0= $0
  • Mod P000052024-10-07+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-01-25+$0$0BLANKET PURCHASE AGREEMENT FOR OCALIVA
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-12-05+$0$02023 PUBLIC LAW PRICING UPDATES
Mod P00002· EXERCISE AN OPTION2022-12-27+$0$0EXERCISE THE FIRST OPTION YEAR ON BPA 36E79722A0011
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-14+$0$02024 PUBLIC LAW PRICING UPDATES.
Mod P00004· EXERCISE AN OPTION2023-12-29+$0$0EXERCISE OPTION YEAR 2
Mod P00005· LEGAL CONTRACT CANCELLATION2024-10-07+$0$0BPA CANCELLATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GHNKCLBJRMK7)

AwardOffice · PSC / listingNet obligationsFY
36E79725A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79724D0180NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C24920F0531249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$49,147FY2020
36C24719K0039247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$4,363FY2019
36C26119F0005261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$26,401FY2019
36C25918F4044NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$4,358FY2018

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722A0011_3600 · retrieved 2026-09-26.